Lin Shen

2.6k total citations
100 papers, 1.4k citations indexed

About

Lin Shen is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Lin Shen has authored 100 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Oncology, 32 papers in Pulmonary and Respiratory Medicine and 16 papers in Surgery. Recurrent topics in Lin Shen's work include Cancer Immunotherapy and Biomarkers (14 papers), Gastric Cancer Management and Outcomes (13 papers) and Lung Cancer Treatments and Mutations (12 papers). Lin Shen is often cited by papers focused on Cancer Immunotherapy and Biomarkers (14 papers), Gastric Cancer Management and Outcomes (13 papers) and Lung Cancer Treatments and Mutations (12 papers). Lin Shen collaborates with scholars based in China, United States and Germany. Lin Shen's co-authors include Walter W. Chan, Joyce Zhou, Kelly Hathorn, Ahmad Najdat Bazarbashi, Walker D. Redd, Thomas R. McCarty, Hongyun Si, Christopher C. Thompson, Wenchao Liu and Danny Wong and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Renewable and Sustainable Energy Reviews.

In The Last Decade

Lin Shen

91 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lin Shen China 21 456 336 258 217 214 100 1.4k
Wen‐Jun Tu China 27 337 0.7× 192 0.6× 755 2.9× 393 1.8× 203 0.9× 92 3.0k
Rui Zheng China 26 173 0.4× 290 0.9× 1.1k 4.1× 63 0.3× 107 0.5× 131 2.7k
Mingwei Wang China 24 427 0.9× 179 0.5× 708 2.7× 173 0.8× 230 1.1× 144 2.4k
Alireza Zali Iran 23 410 0.9× 158 0.5× 266 1.0× 371 1.7× 253 1.2× 194 1.9k
Shuzhen Shi China 12 318 0.7× 113 0.3× 143 0.6× 115 0.5× 48 0.2× 37 965
Li Peng China 24 731 1.6× 500 1.5× 374 1.4× 391 1.8× 321 1.5× 107 2.4k
Peiyu Wang China 21 50 0.1× 148 0.4× 120 0.5× 33 0.2× 224 1.0× 96 1.3k
Yiru Wang China 23 605 1.3× 278 0.8× 440 1.7× 206 0.9× 239 1.1× 105 2.4k

Countries citing papers authored by Lin Shen

Since Specialization
Citations

This map shows the geographic impact of Lin Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Shen more than expected).

Fields of papers citing papers by Lin Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Shen. The network helps show where Lin Shen may publish in the future.

Co-authorship network of co-authors of Lin Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Shen. A scholar is included among the top collaborators of Lin Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Shen. Lin Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shen, Lin, Na Xu, Jie Kong, et al.. (2025). Rare earth elements and yttrium in Chinese coals: Distribution and economic significance. Renewable and Sustainable Energy Reviews. 212. 115423–115423. 4 indexed citations
2.
Qi, Changsong, Lin Shen, Thierry André, et al.. (2025). Efficacy and safety of larotrectinib in patients with TRK fusion gastrointestinal cancer. European Journal of Cancer. 220. 115338–115338. 5 indexed citations
3.
Xu, Na, Li Fei, Mark A. Engle, et al.. (2025). Predicting the Concentrations of Rare Earth Elements and Yttrium in Coal Using Self-Organizing Map. Natural Resources Research. 34(3). 1467–1479. 1 indexed citations
4.
Zhang, Jinchun, Zhi‐Hua Li, Lin Shen, & Xilin Zhou. (2024). Clinical effectiveness of calcitriol and calcium gluconate in treating older male patients with osteoporosis. SHILAP Revista de lepidopterología. 1 indexed citations
5.
Zhang, Panpan, Yanru Qin, Jifang Gong, et al.. (2024). A phase I/II study to evaluate the safety, pharmacokinetics, and efficacy of PRJ1-3024 in patients with advanced solid tumors.. Journal of Clinical Oncology. 42(16_suppl). 2590–2590. 1 indexed citations
6.
7.
Zhang, Panpan, Jifang Gong, Zuoxing Niu, et al.. (2024). Tinengotinib (TT-00420) in combination with atezolizumab in Chinese patients (pts) with biliary tract carcinoma (BTC): Preliminary efficacy and safety results from a phase Ib/II study.. Journal of Clinical Oncology. 42(3_suppl). 473–473. 1 indexed citations
8.
Hong, David S., Ray McDermott, Lin Shen, et al.. (2023). 667P Efficacy and safety of larotrectinib (laro) as first-line treatment for patients (pts) with tropomyosin receptor kinase (TRK) fusion cancer. Annals of Oncology. 34. S469–S469. 3 indexed citations
9.
10.
Gutierrez, Martin, Lin Shen, Bo Gao, et al.. (2023). 681P First-in-human study of ATR inhibitor IMP9064 monotherapy and in combination with PARP inhibitor senaparib in patients with advanced solid tumors. Annals of Oncology. 34. S476–S477. 3 indexed citations
11.
Wang, Yakun, Jifang Gong, Rongbo Lin, et al.. (2023). First-in-human dose escalation and expansion study of SYSA1801, an antibody-drug conjugate targeting claudin 18.2 in patients with resistant/refractory solid tumors.. Journal of Clinical Oncology. 41(16_suppl). 3016–3016. 22 indexed citations
12.
13.
Shen, Lin, et al.. (2021). Harnessing Event Report Data to Identify Diagnostic Error During the COVID-19 Pandemic. The Joint Commission Journal on Quality and Patient Safety. 48(2). 71–80. 5 indexed citations
14.
Gong, Zimu, Wacili Da, Yihao Tian, et al.. (2021). Exogenous melatonin prevents type 1 diabetes mellitus–induced bone loss, probably by inhibiting senescence. Osteoporosis International. 33(2). 453–466. 12 indexed citations
15.
Hajifathalian, Kaveh, Reem Z. Sharaiha, Sonal Kumar, et al.. (2020). Development and external validation of a prediction risk model for short-term mortality among hospitalized U.S. COVID-19 patients: A proposal for the COVID-AID risk tool. PLoS ONE. 15(9). e0239536–e0239536. 19 indexed citations
16.
Si, Hongyun, Lin Shen, Wenchao Liu, & Guangdong Wu. (2020). Uncovering people’s mask-saving intentions and behaviors in the post-COVID-19 period: Evidence from China. Sustainable Cities and Society. 65. 102626–102626. 61 indexed citations
17.
Redd, Walker D., Joyce Zhou, Kelly Hathorn, et al.. (2020). Prevalence and Characteristics of Gastrointestinal Symptoms in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection in the United States: A Multicenter Cohort Study. Gastroenterology. 159(2). 765–767.e2. 234 indexed citations
18.
Yuan, Jia, et al.. (2020). Determination of a novel photosensitizer sinoporphyrin sodium in human plasma by ultra-performance liquid chromatography–tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 195. 113852–113852. 1 indexed citations
19.
Ma, Chen, Lin Shen, Yanping Yang, et al.. (2016). Correlation of carcinoembryonic antigen-related cell adhesion molecule 1 and adiponectin signaling pathway related molecules in non-traumatic necrosis of the femoral head. Zhonghua shiyan waike zazhi. 33(5). 1405–1408. 1 indexed citations
20.
Shou, Dahua, Yu Dong, Lin Shen, et al.. (2013). Rapid Quantification of Tobramycin and Vancomycin by UPLC-TQD and Application to Osteomyelitis Patient Samples. Journal of Chromatographic Science. 52(6). 501–507. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wen‐Jun Tu Breakdown of academic impact, for papers by Rui Zheng Breakdown of academic impact, for papers by Mingwei Wang Breakdown of academic impact, for papers by Alireza Zali Breakdown of academic impact, for papers by Shuzhen Shi Breakdown of academic impact, for papers by Li Peng Breakdown of academic impact, for papers by Peiyu Wang Breakdown of academic impact, for papers by Yiru Wang
Rankless by CCL
2026